Select Page


ivWatch has partnered with leaders in the medical device and health care space to allow institutions to reduce patient harm and improve patient safety by providing continuous monitoring technology for the early detection of IV infiltrations and extravasations.

ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, entered into a long-term development and commercialization agreement with ICU Medical, a worldwide leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications. The collaboration will offer a way forward for Electronic Health Records (EHR) interoperability by connecting the two companies’ systems in order to exchange and use high-quality data.

ivWatch has announced compatibility with Philips IntelliVue Patient Monitors with the inclusion of point-of-connectivity. As the only provider of continuous non-invasive monitoring devices for the early detection of peripheral intravenous (IV) infiltrations and extravasations, ivWatch now supports Philips IntelliVue Patient Monitors for in-room and remote notifications and electronic medical record (EMR) data capture.

ivWatch and Terumo have a licensing and distribution agreement with Terumo to help improve patient safety. As part of the agreement, Terumo Corporation is named as the exclusive distributor for ivWatch in Japan and has licensed ivWatch continuous IV infiltration detection technology for use in its products globally.
As the market leader for continuous IV infiltration and extravasation detection technology, ivWatch and Terumo Corporation, one of the world’s leading medical device manufacturers and distributors, have agreed that Terumo will be the exclusive distributor of the ivWatch Model 400 and the ivWatch OEM board in Japan, and is a global licensing partner for Terumo products containing the ivWatch OEM board.**

ivWatch has been designated a Vizient awarded supplier by Vizient, Inc., the largest member-driven health care performance improvement company in the country. The ivWatch Model 400 has earned an Innovative Technology designation based on recommendations for the device by providers with expertise in this category who serve on one of Vizient’s member-led councils. Innovative Technology contracts are reserved for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organization’s care delivery and business model.

Vizient-served members can contact their Vizient account manager or access additional information on the ivWatch Model 400 through the Vizient member portal.

ivWatch has been designated a Breakthrough Technology Contracted Supplier with Premier, Inc., a leading healthcare improvement company, uniting an alliance of approximately 3,900 U.S. hospitals and 150,000 other providers to transform healthcare. The Breakthrough Technology program accelerates the standard GPO process and enables ivWatch to educate more organizations about our technology offering a new standard of care for PIVs. Recognition as a Breakthrough Technology is a testament to the need for a technology solution in hospitals for continuous IV monitoring for early detection of IV infiltrations and extravasations.

Premier members can contact their Premier account manager or access additional information on the ivWatch Model 400 through the Premier member portal. Please reference contract number PP-NS-1123.

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

This form does not exist

You have Successfully Subscribed!

Pin It on Pinterest